Investment Thesis
HealthEquity demonstrates exceptional financial health with 69.5% gross margins, 24.6% operating margins, and exceptional 34.7% free cash flow conversion, indicating a highly efficient capital-light business model. Net income surged 122.5% YoY with strong operational cash flow generation and conservative 0.45x debt-to-equity leverage, though moderate 9.5% revenue growth limits upside potential and ROE of 10.2% suggests capital deployment could be optimized.
Strengths
- Outstanding profitability with 16.4% net margin and 122.5% YoY net income growth driven by operational leverage
- Exceptional cash generation with 455.1M free cash flow (34.7% FCF margin) and minimal capex requirements indicating highly scalable business
- Strong financial fortress with 3.27x current ratio, 27.3x interest coverage, and conservative 0.45x debt-to-equity ratio
- Premium gross margins of 69.5% and operating margins of 24.6% indicate strong competitive moat and pricing power
Risks
- Revenue growth of 9.5% YoY is moderate; concerning if growth trajectory is decelerating further
- ROE of 10.2% is underwhelming despite strong profitability, suggesting capital may be deployed inefficiently or underutilized
- Exceptional 122.5% net income growth may be unsustainable if driven by one-time margin expansions, share buybacks, or favorable tax items rather than organic revenue growth
- Business services sector exposure to economic cycles and potential regulatory changes affecting customer demand
Key Metrics to Watch
- Revenue growth acceleration/deceleration trends—critical to validate 9.5% is sustainable or expanding
- Gross and operating margin stability—determine if 122.5% net income growth is recurring or dependent on one-time factors
- Free cash flow generation and capex trends—monitor if capital-light model persists and FCF is deployed toward debt reduction
- Customer acquisition costs and retention rates—proxy for competitive positioning and market saturation
Financial Metrics
Revenue
1.3B
Net Income
215.2M
EPS (Diluted)
$2.46
Free Cash Flow
455.1M
Total Assets
3.4B
Cash
318.9M
Profitability Ratios
Gross Margin
69.5%
Operating Margin
24.6%
Net Margin
16.4%
ROE
10.2%
ROA
6.4%
FCF Margin
34.7%
Balance Sheet & Liquidity
Current Ratio
3.27x
Quick Ratio
3.27x
Debt/Equity
0.45x
Debt/Assets
37.7%
Interest Coverage
27.34x
Long-term Debt
957.4M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-04-11T07:57:25.007419 |
Data as of: 2026-01-31 |
Powered by Claude AI